GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Net Income (Continuing Operations)

DuChemBio Co (XKRX:176750) Net Income (Continuing Operations) : ₩4,001 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. DuChemBio Co's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was ₩4,001 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,001 Mil.

DuChemBio Co Net Income (Continuing Operations) Historical Data

The historical data trend for DuChemBio Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Net Income (Continuing Operations) Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial -12,139.83 -7,876.23 1,447.05 -2,831.53 4,000.51

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations) Get a 7-Day Free Trial -12,139.83 -7,876.23 1,447.05 -2,831.53 4,000.51

DuChemBio Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,001 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DuChemBio Co  (XKRX:176750) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

DuChemBio Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

DuChemBio Co (XKRX:176750) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:002620 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:002390 XKRX:061250 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:293780 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
Website
http://www.duchembio.com
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines